| Isolation and investigation of presumptive murine lacrimal gland stem cells P Ackermann, S Hetz, J Dieckow, M Schicht, A Richter, C Kruse, ... Investigative ophthalmology & visual science 56 (8), 4350-4363, 2015 | 40 | 2015 |
| Adipose-derived stem/stromal cells recapitulate aging biomarkers and show reduced stem cell plasticity affecting their adipogenic differentiation capacity JS Jung, C Volk, C Marga, A Navarrete Santos, M Jung, D Rujescu, ... Cellular reprogramming 21 (4), 187-199, 2019 | 32 | 2019 |
| Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development? A Appelt‐Menzel, S Oerter, S Mathew, U Haferkamp, C Hartmann, M Jung, ... Current protocols in stem cell biology 55 (1), e122, 2020 | 31 | 2020 |
| Hypoxia supports reprogramming of mesenchymal stromal cells via induction of embryonic stem cell–specific microRNA-302 cluster and pluripotency-associated genes S Foja, M Jung, B Harwardt, D Riemann, O Pelz-Ackermann, ... Cellular Reprogramming (Formerly" Cloning and Stem Cells") 15 (1), 68-79, 2013 | 31 | 2013 |
| Infection of iPSC lines with miscarriage-associated coxsackievirus and measles virus and teratogenic rubella virus as a model for viral impairment of early human embryogenesis D Hübner, K Jahn, S Pinkert, J Böhnke, M Jung, H Fechner, D Rujescu, ... ACS infectious diseases 3 (12), 886-897, 2017 | 15 | 2017 |
| Influence of growth characteristics of induced pluripotent stem cells on their uptake efficiency for layer-by-layer microcarriers U Reibetanz, D Hübner, M Jung, UG Liebert, C Claus ACS nano 10 (7), 6563-6573, 2016 | 15 | 2016 |
| Pluripotent stem cell-based models: a peephole into virus infections during early pregnancy C Claus, M Jung, JM Hübschen Cells 9 (3), 542, 2020 | 9 | 2020 |
| Glycation increases the risk of microbial traversal through an endothelial model of the human blood-brain barrier after use of anesthetics V Weber, H Olzscha, T Längrich, C Hartmann, M Jung, B Hofmann, ... Journal of Clinical Medicine 9 (11), 3672, 2020 | 7 | 2020 |
| Immune cell puzzle COVID-19: how do SARS-CoV infections contribute to psychiatric diseases? M Jung, D Rujescu European Archives of Psychiatry and Clinical Neuroscience 270 (6), 643-644, 2020 | 5 | 2020 |
| Translational medicine: from disease-and patient-specific stem cell research to clinical trials and back again M Jung, D Rujescu European archives of psychiatry and clinical neuroscience 266, 679-680, 2016 | 5 | 2016 |
| Generation of a set of induced pluripotent stem cell lines from two Alzheimer disease patients carrying APOE4 (MLUi007-J; MLUi008-A) and healthy old donors carrying APOE3 … M Jung, C Hartmann, T Ehrhardt, LM Peter, CL Abid, B Harwardt, ... Stem Cell Research 69, 103072, 2023 | 4 | 2023 |
| Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression J Böhnke, S Pinkert, M Schmidt, H Binder, NC Bilz, M Jung, U Reibetanz, ... International Journal of Molecular Sciences 22 (3), 1220, 2021 | 3 | 2021 |
| Generation of neural stem cells from pluripotent stem cells for characterization of early neuronal development M Jung, J Schiller, C Hartmann, J Pfeifer, D Rujescu In Vitro Models for Stem Cell Therapy: Methods and Protocols, 233-244, 2021 | 2 | 2021 |
| Neuronal Stem Cells from Late-Onset Alzheimer Patients Show Altered Regulation of Sirtuin 1 Depending on Apolipoprotein E Indicating Disturbed Stem Cell Plasticity M Jung, JS Jung, J Pfeifer, C Hartmann, T Ehrhardt, CL Abid, J Kintzel, ... Molecular Neurobiology 61 (3), 1562-1579, 2024 | 1 | 2024 |
| Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease U Haferkamp, C Hartmann, CL Abid, A Brachner, A Höchner, A Gerhartl, ... Fluids and Barriers of the CNS 20 (1), 78, 2023 | 1 | 2023 |
| Disease‐Specific Stem Cell Models for Toxicological Screenings and Drug Development M Jung, JS Jung, J Schiller, IS Schroeder Stem Cells in Toxicology and Medicine, 122-144, 2016 | 1 | 2016 |
| Establishment of an in vitro patient-derived hiPSC-based blood-brain barrier model of Syngap1 disorder N Kardos-Török, A Gerhartl, A Brachner, C Rojas, G Rumbaugh, ... | | 2024 |
| Comparison of Extracellular Vesicles from Induced Pluripotent Stem Cell-Derived Brain Cells G Xavier, A Navarrete Santos, C Hartmann, ML Santoro, N Flegel, ... International Journal of Molecular Sciences 25 (7), 3575, 2024 | | 2024 |
| Induced pluripotent stem cell-derived brain cell models as tools to study late-onset Alzheimer's disease CL Abid, E Tan, J Feldhaus, T Hollemann, M Jung ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE 55 (SUPPL 1), 35-35, 2022 | | 2022 |
| An Alzheimer´ s disease-specific iPSC-derived blood-brain barrier model to study the role of APOE4 C Hartmann, U Haferkamp, A Gerhartl, LM Peter, O Pless, W Neuhaus, ... 10th International Meeting Stem Cell Network North Rhine-Westphalia, 2021 | | 2021 |
